Nicolas Keller

720 total citations
18 papers, 322 citations indexed

About

Nicolas Keller is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Nephrology. According to data from OpenAlex, Nicolas Keller has authored 18 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Nephrology. Recurrent topics in Nicolas Keller's work include COVID-19 Clinical Research Studies (4 papers), Dialysis and Renal Disease Management (3 papers) and Blood Pressure and Hypertension Studies (3 papers). Nicolas Keller is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), Dialysis and Renal Disease Management (3 papers) and Blood Pressure and Hypertension Studies (3 papers). Nicolas Keller collaborates with scholars based in France, Germany and Poland. Nicolas Keller's co-authors include Peggy Perrin, Sophie Caillard, Samira Fafi‐Kremer, Bruno Moulin, Gabriela Gautier-Vargas, Joachim Neumann, Iliès Benotmane, Ulrich Gergs, Seyyid Baloglu and Henning Ebelt and has published in prestigious journals such as American Journal of Physiology-Heart and Circulatory Physiology, Transplantation and ChemSusChem.

In The Last Decade

Nicolas Keller

17 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Keller France 8 123 108 92 65 45 18 322
Sergiy G. Gychka Ukraine 7 131 1.1× 94 0.9× 72 0.8× 30 0.5× 13 0.3× 22 316
Roozbeh Tarighati Rasekhi United States 7 338 2.7× 203 1.9× 71 0.8× 185 2.8× 9 0.2× 11 537
Jackson Walker United States 4 252 2.0× 182 1.7× 27 0.3× 121 1.9× 11 0.2× 8 395
Scott Anjewierden United States 6 290 2.4× 152 1.4× 29 0.3× 66 1.0× 11 0.2× 12 398
Marina Rieder Germany 9 120 1.0× 44 0.4× 56 0.6× 71 1.1× 6 0.1× 31 294
Lizhen Yang China 9 120 1.0× 48 0.4× 46 0.5× 27 0.4× 6 0.1× 20 344
Jian Mao China 9 95 0.8× 80 0.7× 43 0.5× 9 0.1× 10 0.2× 23 323
Zachary Manickas-Hill United States 5 224 1.8× 260 2.4× 84 0.9× 18 0.3× 2 0.0× 6 388
Hongjie Hou China 11 101 0.8× 55 0.5× 49 0.5× 31 0.5× 4 0.1× 17 267

Countries citing papers authored by Nicolas Keller

Since Specialization
Citations

This map shows the geographic impact of Nicolas Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Keller more than expected).

Fields of papers citing papers by Nicolas Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Keller. The network helps show where Nicolas Keller may publish in the future.

Co-authorship network of co-authors of Nicolas Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Keller. A scholar is included among the top collaborators of Nicolas Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Keller. Nicolas Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Keller, Nicolas, et al.. (2024). Safety and efficacy of colchicine in crystal-induced arthritis flare in 54 patients with severe chronic kidney disease. RMD Open. 10(1). e003872–e003872. 3 indexed citations
3.
Keller, Nicolas, et al.. (2024). Enhancing vascular access planning in CKD: validating the 40% KFRE threshold for predicting ESKD in a French retrospective cohort study. Clinical Kidney Journal. 17(8). sfae220–sfae220. 1 indexed citations
4.
Benotmane, Iliès, Jérôme Olagne, Gabriela Gautier-Vargas, et al.. (2023). Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients. Transplantation. 107(8). e215–e218. 2 indexed citations
5.
Hannedouche, Thierry, Cécile Couchoud, François Chantrel, et al.. (2022). Diabetic kidney disease versus non‐diabetic kidney disease in type 2 diabetic patients on dialysis: An observational cohort. Endocrinology Diabetes & Metabolism. 5(4). e00281–e00281. 2 indexed citations
6.
Benotmane, Iliès, Aurélie Velay, Gabriela Gautier-Vargas, et al.. (2022). Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients. American Journal of Transplantation. 22(11). 2675–2681. 35 indexed citations
7.
Keller, Nicolas, Alexandra Monnier, Sophie Caillard, et al.. (2021). High‐flow arteriovenous fistula and hemodynamic consequences at 1 year after kidney transplantation. Seminars in Dialysis. 35(2). 171–180. 1 indexed citations
8.
Krummel, Thierry, et al.. (2021). Effects of high- vs low-dose native vitamin D on albuminuria and the renin–angiotensin–aldosterone system: a randomized pilot study. International Urology and Nephrology. 54(4). 895–905. 7 indexed citations
9.
Perrin, Peggy, Nicolas Collongues, Seyyid Baloglu, et al.. (2020). Cytokine release syndrome‐associated encephalopathy in patients with COVID‐19. European Journal of Neurology. 28(1). 248–258. 109 indexed citations
10.
Keller, Nicolas, et al.. (2020). Impact of first-wave COronaVIrus disease 2019 infection in patients on haemoDIALysis in Alsace: the observational COVIDIAL study. Nephrology Dialysis Transplantation. 35(8). 1338–1411. 29 indexed citations
11.
Keller, Nicolas, et al.. (2019). Médicaments du système cardiovasculaire et fonction rénale : les pièges de l’adaptation rénale. Néphrologie & Thérapeutique. 15(2). 97–103. 1 indexed citations
13.
Krummel, Thierry, et al.. (2019). Hemodialysis without anticoagulation: Less clotting in conventional hemodialysis than in predilution hemodiafiltration. Hemodialysis International. 23(4). 426–432. 6 indexed citations
14.
Keller, Nicolas, Anne Conrad, Samira Fafi‐Kremer, et al.. (2019). Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: A multicenter retrospective study. Transplant Infectious Disease. 21(2). e13058–e13058. 16 indexed citations
15.
Keller, Nicolas, Stefan Dhein, Joachim Neumann, & Ulrich Gergs. (2018). Cardiovascular effects of cisapride and prucalopride on human 5-HT4 receptors in transgenic mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 391(9). 975–985. 13 indexed citations
16.
Keller, Nicolas, Thierry Krummel, & Thierry Hannedouche. (2018). Sodium, hypertension, maladies rénales et santé publique. Néphrologie & Thérapeutique. 14. S93–S98. 2 indexed citations
17.
Gergs, Ulrich, Anne Böckler, Henning Ebelt, et al.. (2013). Human 5-HT4 receptor stimulation in atria of transgenic mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 386(5). 357–367. 42 indexed citations
18.
Gergs, Ulrich, Martin Baumann, Anne Böckler, et al.. (2010). Cardiac overexpression of the human 5-HT4receptor in mice. American Journal of Physiology-Heart and Circulatory Physiology. 299(3). H788–H798. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026